Berries Health & Genetics Laboratory

Our Founder

Dr. Seyed Ali Hosseini MD, PhD, FACMG, ABB(HCLD) is a distinguished professional in the field of clinical molecular genetics, holding dual certifications from the American Board of Medical Genetics & Genomics and the American Board of Bioanalysis (HCLD). As the visionary founder of Berries Health and Genetics, he brings a wealth of expertise and experience to the forefront of healthcare and genomics. His vision is supported by the staff of highly skilled scientists, physicians, pharmacists, business development professionals, and of course, by loyal customers.

Prior to his entrepreneurial venture, Dr. Hosseini served as the Clinical Pharmacogenomics Director at Invitae-Pharmacogen laboratory, where he played a pivotal role in advancing the understanding of personalized medicine. His leadership extended to Resolution Bioscience, where he served as Director of the Clinical Laboratory and Clinical Affairs, specializing in liquid biopsy-cancer. Notably, he directed clinical and medical operations at Claritas Genomics, a spin-off from Boston Children’s Hospital, focusing on inherited rare genetic disorders. During his tenure, he actively participated in training clinical molecular genetics and molecular pathology fellows in whole-exome sequencing.

Dr. Hosseini’s dedication to advancing medical knowledge is underscored by his involvement in numerous clinical trials, spanning RUO, Phase 1, 2, and 3 studies, as well as PMA and 510K assays in collaboration with pharmaceutical companies. His profound understanding of GXP regulations is reflected in his role in training laboratory staff for Good Clinical Laboratory Practice (GCLP). Notably, he is a respected member of CPIC (Clinical Pharmacogenetics Implementation Consortium) and ClinGen, showcasing his commitment to staying at the forefront of genetic advancements.

Educated at the University of Miami and Boston Children’s Hospital (Harvard Medical School), Dr. Hosseini completed his clinical molecular genetics training. His medical journey began with an MD from Iran, followed by a post-doctoral focus on cancer genetics at Ohio State University. Fluent in both Farsi and English, Dr. Hosseini’s multicultural proficiency enriches his ability to engage with diverse stakeholders.

Dr. Hosseini’s passion lies in precision medicine and personalized patient treatment based on molecular assays. His extensive background, encompassing various aspects of genetics and genomics, positions him as a thought leader in the pursuit of cutting-edge solutions for healthcare challenges.

Our Company

Berries Health & Genetics is a contract research and diagnostics organization (CRO/CDO) that is focused on advancing personalized medicine and improving patient outcomes.

As the name suggests, the company has two branches: the health and wellness branch and the genetics laboratory branch.

First, Patients and doctors express that patients are treated reactively more often than not, addressing health issues as they arise. However, a proactive approach that involves monitoring patients regularly whether or not they are experiencing symptoms can lead to early detection of potential health problems and allow for timely intervention. Berries Health & Genetics offers wellness programs that comprehensively monitor patient health multiple times a year. By monitoring patients on a more frequent schedule, doctors can identify trends, assess risk factors, and implement preventive measures, leading to improved patient outcomes and a shift towards proactive and preventive healthcare.

Second, medical staff and researchers express that resource gaps and constraints are one of the top roadblocks to accelerated innovation in personalized healthcare and research.

To overcome the challenge of acquiring the necessary infrastructure and expertise, many companies often are faced by the need to manage multiple vendors or rely on a single diagnostic company with limited resources. As a contract diagnostics organization, Berries Health and Genetics presents a groundbreaking solution by streamlining this complex process and enabling the incorporation of cutting-edge molecular technologies into the development process. The company offers cost-effectiveness, flexibility, dynamic solutions, and optimal deployment of various laboratory solutions for partners and projects at any scale.